Citations

Institution: Mayo Clinic Clear

Showing 10 of 108094 citations.

Exploring Risk and Protective Factors: Understanding Nonmedical Stimulant Use Among Florida High School Students
Hamadi, Hanadi , Thomas, Rachel McMahan, Xie, Zhigang, Patterson, Karen B., Spaulding, Aaron, Spaulding, Aaron , Spaulding, Aaron , Hamadi, Hanadi Y , Thomas, Rachel McMahan, Xie, Zhigang, Patterson, Karen B.

Journal of Drug Issues | July 29, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/00220426251364375 Get It

Nonmedical stimulant use (NMSU) among adolescents poses significant public health concerns. Using cross-sectional design, this study examined risk and protective factors for NMSU among 20,576 Florida high school students using the 2020 Florida Youth Substance Abuse Survey, with 925 students reporting NMSU. Guided by Hawkins and Catalano’s Social Development Model, we employed multivariate logistic regression analyses to estimate adjusted odds ratios while controlling for demographics. Students engaged in extracurricular activities were 50% less likely to report NMSU. Higher academic performance was associated with lower NMSU likelihood. Students with friends who used stimulants nonmedically were significantly more likely to engage in NMSU (AOR, 7.60; 95% CI: 6.35, 9.10), as were those living with relatives who used substances (AOR, 3.54; 95% CI: 2.94, 4.26). Findings highlight the importance of extracurricular involvement and positive social networks in mitigating NMSU. Interventions addressing family, peers, and extracurricular involvement are crucial for prevention and evidence-based policies.
Rapid Response Events Prompt Increased Goals of Care Discussions and Code Status Changes
Friesen, Joelle N. , Wanberg, Erik J. , Allman, Alexandra , Pennington, Kelly M. , LeMahieu, Allison , Moraes, Alice Gallo de

American Journal of Hospice and Palliative Medicine® | July 29, 2025 | Volume: 43 | Issue: 10 | Pages: 1082-1089

10.1177/10499091251363899 | PMID 40729745 Get It

Background While rapid response teams (RRT) are widely implemented to address clinical deterioration in hospitalized patients, their impact on goals of care (GOC) discussions remains underexplored. Aims We aimed to evaluate whether RRT activations were associated with subsequent goals of care discussions, code status changes, and clinical outcomes. Methods We conducted a retrospective single-center review of hospitalized adult patients admitted to medicine services who had RRT activations between January and December 2023. The primary outcome was GOC discussion within 72 h of RRT. GOC discussions were identified through EMR documentation of conversations, code status changes, and ACP notes. Secondary outcomes included code status change, transition to comfort care, and 30- and 90-day mortality. Analyses were adjusted using inverse probability of treatment weighting. Results 1823 RRTs among 1677 patients were analyzed; 47% of patients were female and 88% identified as white. Those transferred to the ICU had higher odds of goals of care discussions (OR 1.52, P < 0.001), code status change (OR 2.43, P < 0.001), and transition to comfort care (OR 1.47, P = 0.026) compared to those who remained on the floor. ICU transfer was also associated with increased 30- (OR 1.39, P = 0.006) and 90-day mortality (OR 1.30, P = 0.014). Conclusions ICU transfer following RRT activation is strongly associated with downstream goals of care discussions, changes in code status, comfort-focused care, and higher mortality. This demonstrates the importance of initiating goals of care discussions early and often, regardless of whether clinical decompensation is anticipated.
Impact of Modifiable Surgical Factors on Ossiculoplasty Outcomes After Controlling for Ear Environment Risk: A Multi-Institutional Study
Judd, Ryan T. , Gluth, Michael B. , Dornhoffer, John L., Carlson, Matthew L. , Kuthubutheen, Jafri , Anderson, Ryan D., Sakai, Mark , Barnes, Jason H. , Fussell, Wanda L., Gurgel, Richard Klaus , Isaacson, Brandon , Hui, Ng Jia, Quick, Mark E. , Anderson, Ryan D.

Otology & Neurotology | July 29, 2025 | Volume: 46 | Issue: 10 | Pages: 1280-1288

10.1097/mao.0000000000004611 | PMID 40729578 Get It

Objective: To determine the impact of modifiable surgical factors on ossiculoplasty outcomes after controlling for ear environment risk. Study Design: Multi-institutional retrospective review. Setting: Six tertiary care centers from 2011 to 2019. Patients Adults and children. Interventions: Ossiculoplasty, including synthetic ossicular replacement prosthesis, autograft interposition, bone cement repair, and mobilization. Main Outcome Measure: Correlation between modifiable surgical factors and pure-tone average air-bone gap (ABG) at most recent audiogram after controlling for preoperative risk using the statistically validated Ear Environment Risk (EER) score. Results: A total of 1,679 cases were included with a median follow-up time of 20 months (IQR, 5–51). After controlling for EER score, malleus engagement of prosthesis yielded favorable ABG versus direct contact to tympanic membrane without malleus engagement (beta = −2.4 dB [−3.8, −1.1], p < 0.001). For total ossicular replacement prostheses (TORP), use of a footplate prosthesis yielded favorable ABG as compared with no footplate prosthesis (−3.6 dB [−6.1, −1.1], p = 0.005). For synthetic prostheses, polyethylene prostheses had a less favorable ABG compared with full titanium or titanium with hydroxyapatite prostheses ( p < 0.05). In cases where the malleus was not engaged in reconstruction, amputation of the malleus head yielded worse ABG (+3.9 dB [1.2, 6.7], p = 0.005). There was no significant difference ( p > 0.05) in ABG for single-stage versus multistaged approach, use of a cartilage cap over the prosthesis versus no cartilage, use of bone cement to secure a PORP to the stapes versus no cement, mastoid cavity obliteration versus no obliteration, and incudostapedial joint reconstruction with joint prosthesis/bone cement versus synthetic PORP. Conclusions: With statistical correction for ear environment risk, several modifiable surgical factors are noted to impact ossiculoplasty hearing outcomes. Level of Evidence: 4.
A Cure, a Cure, My Kingdom for a Cure…
Kumar, Shaji , Kumar, Shaji K , Lonial, Sagar

Journal of Clinical Oncology | July 29, 2025 | Volume: 43 | Issue: 25 | Pages: 2763-2765

10.1200/jco-25-01258 | PMID 40729626 Get It

Teleportation: Defense Against Stealing Attacks of Data-Driven Healthcare APIs
Wang, Zhenyi , Shen, Li , Luan, Siyu , Li, Fang , Doretto, Gianfranco , Adjeroh, Donald , Niu, Shuteng , Li, Jianfu , Tao, Cui , Tao, Cui , Niu, Shuteng , Li, Jianfu , Li, Fang , Duan, Tiehang , Shen, Li , Luan, Siyu

IEEE Transactions on Artificial Intelligence | July 29, 2025 | Volume: 7 | Issue: 3 | Pages: 1273-1289

10.1109/tai.2025.3593470 Get It

Alzheimer's Association Clinical Practice Guideline on the use of blood‐based biomarkers in the diagnostic workup of suspected Alzheimer's disease within specialized care settings
Whitson, Heather E. , Allen, Laura A., Galasko, Douglas, Okrahvi, Hamid R., Paczynski, Madeline , Carrillo, Marı́a C., Edelmayer, Rebecca M. , McAteer, Mary Beth , Pahlke, Sarah , Tampi, Malavika P. , Carrillo, María C. , Palmqvist, Sebastian , Suárez‐Calvet, Marc , Karikari, Thomas K. , Schindler, Suzanne E. , Teunissen, Charlotte E. , Zetterberg, Henrik , Mahinrad, Simin , Kahale, Lara A

Alzheimer's & Dementia | July 29, 2025 | Volume: 21 | Issue: 7 | Pages: No page available

10.1002/alz.70535 | PMID 40729527 Get It

Abstract OBJECTIVE AND SCOPE A panel of clinicians, subject‐matter experts, and guideline methodologists convened by the Alzheimer's Association conducted a systematic review and formulated evidence‐based recommendations for using blood‐based biomarkers (BBMs) in the diagnostic workup of suspected Alzheimer's disease (AD) within specialized care settings. The scope focuses on individuals with objective cognitive impairment, including those with mild cognitive impairment (MCI) or dementia, who are undergoing evaluation by providers trained and experienced in memory disorders, where AD is the suspected underlying etiology. METHODS The panel conducted a systematic review to assess the diagnostic accuracy of BBMs in detecting AD pathology. The BBMs of interest included plasma phosphorylated‐tau (p‐tau) and amyloid‐beta (Aβ) tests measuring the following analytes: p‐tau217, ratio of p‐tau217 to non‐p‐tau217 ×100 (%p‐tau17), p‐tau181, p‐tau231, and ratio of Aβ42 to Aβ40. The reference standard tests included cerebrospinal fluid (CSF) AD biomarkers, amyloid positron emission tomography (PET), or neuropathology. The panel applied the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach to assess the certainty of the evidence and the GRADE evidence‐to‐decision (EtD) Framework to develop its recommendations. RECOMMENDATIONS The key recommendations in this Clinical Practice Guideline (CPG) are: (1) BBM tests with ≥90% sensitivity and ≥75% specificity can be used as a triaging test and (2) BBM tests with ≥90% sensitivity and specificity can serve as a substitute for amyloid PET imaging or CSF AD biomarker testing in patients with cognitive impairment presenting to specialized care for memory disorders. The panel cautions users of this guideline that there is significant variability in diagnostic test accuracy and many commercially available BBM tests do not meet these thresholds, especially using a single cutoff. Additionally, these tests do not serve as a substitute for comprehensive clinical evaluation by a healthcare professional and should be used only as part of a full diagnostic workup of patients with cognitive impairment presenting to specialized care settings, and with careful consideration of pretest probability of AD pathology. CONCLUSIONS AND PRACTICAL IMPLICATIONS This CPG provides performance‐based, brand‐agnostic recommendations for the use of BBMs in the diagnostic workup of suspected AD within specialized care settings. By linking recommendations to a systematic review and associated living updates, and using a robust and transparent methodology, the guideline ensures scientific rigor, adaptability, and sustained relevance as evidence evolves. Clinicians are encouraged to stay informed about emerging paradigms—such as biomarker combinations or ratios and multi‐threshold testing—that may further refine the diagnostic accuracy of BBMs as the field evolves.
Decoding large language models for radiology: strategies for fine-tuning and prompt engineering
Vahdati, Sanaz , Ganjizadeh, Ali , Ganjizadeh, Ali , Chao, Chiehju, Mahmoudi, Elham , Chao, Chieh‐Ju , Erickson, Bradley J.

Radiology Advances | July 29, 2025 | Volume: 2 | Issue: 4 | Pages: No page available

10.1093/radadv/umaf024 | PMID 41058957 Get It

Abstract The advances in large language models (LLMs) have demonstrated sophisticated potential for automating complex tasks within the radiology workflow. From radiology report generation and report summarization to data collection for research trials, these models have proven to be powerful tools. However, optimal implementation of these models requires careful adaptation to the specialized medical domain. In addition, these models tend to generate information that is not truthful or factual, which can adversely affect patient care and clinical decisions. Strategies such as fine-tuning and prompt optimization have been shown to be impactful in eliminating these errors. Although these models undergo rapid updates and improvements, understanding the principles of prompt engineering and fine-tuning provides a foundation for evaluating and maintaining the performance of any LLM deployment. The current article aims to review the recent advancements in radiology using fine-tuning and prompt optimization to leverage LLMs’ capabilities. It delves into various techniques within each strategy, their advantages and limitations, and presents a framework to facilitate the practical integration of LLMs into radiology settings.
New Imaging Method of Mobile Phone-Based Colorimetric Sensor for Iron Quantification
Nguyen, Ngan Anh, Hendricks, Asher, Montoya, Emily, Mayers, Amber, Rajmohan, Diwitha, Morrin, Aoife , McCaul, Margaret , Dunne, Nicholas , Spanias, Andreas , Raupp, Gregory B. , Forzani, Erica , Montoya, Emily, Mayers, Amber, O'Connor, Noel Edward

Sensors | July 29, 2025 | Volume: 25 | Issue: 15 | Pages: 4693

10.3390/s25154693 | PMID 40807858 Get It

Blood iron levels are related to many health conditions, affecting hundreds of millions of individuals worldwide. To aid in the prevention and treatment of iron-related disorders, previous research has developed a low-cost, accurate, point-of-care method for measuring iron from a single finger-prick blood sample. This study builds upon that work by introducing an improved imaging method that accurately reads sensor images irrespective of variations in environmental illumination and camera quality. Smartphone cameras were used as analytical tools, demonstrating an average coefficient of variation of 5.13% across different phone models, and absorbance results were found to be improved by 8.80% compared to the method in a previous study. The proposed method successfully enhances iron detection accuracy under diverse lighting conditions, paving the way for smartphone-based sensing of other colorimetric reactions involving various analytes.
Sensitivity of Diffusion Tensor Imaging for Assessing Injury Severity in a Rat Model of Isolated Diffuse Axonal Injury: Comparison with Histology and Neurological Assessment
Zvenigorodsky, Vladislav , Gruenbaum, Benjamin F. , Shelef, Ilan , Frank, Dmitry , Tsafarov, Beatris, Negev, Shahar, Zeldetz, Vladimir, Azab, Abed N., Boyko, Matthew , Gruenbaum, Benjamin Fredrick , Boyko, Matthew , Shelef, Ilan , Zlotnik, Alexander Anatolievich

International Journal of Molecular Sciences | July 29, 2025 | Volume: 26 | Issue: 15 | Pages: 7333

10.3390/ijms26157333 | PMID 40806467 Get It

Diffuse axonal brain injury (DAI) is a common, debilitating consequence of traumatic brain injury, yet its detection and severity grading remain challenging in clinical and experimental settings. This study evaluated the sensitivity of diffusion tensor imaging (DTI), histology, and neurological severity scoring (NSS) in assessing injury severity in a rat model of isolated DAI. A rotational injury model induced mild, moderate, or severe DAI in male and female rats. Neurological deficits were assessed 48 h after injury via NSS. Magnetic resonance imaging, including DTI metrics, such as fractional anisotropy (FA), relative anisotropy (RA), axial diffusivity (AD), mean diffusivity (MD), and radial diffusivity (RD), was performed prior to tissue collection. Histological analysis used beta amyloid precursor protein immunohistochemistry. Sensitivity and variability of each method were compared across brain regions and the whole brain. Histology was the most sensitive method, requiring very small groups to detect differences. Anisotropy-based MRI metrics, especially whole-brain FA and RA, showed strong correlations with histology and NSS and demonstrated high sensitivity with low variability. NSS identified injury but required larger group sizes. Diffusivity-based MRI metrics, particularly RD, were less sensitive and more variable. Whole-brain FA and RA were the most sensitive MRI measures of DAI severity and were comparable to histology in moderate and severe groups. These findings support combining NSS and anisotropy-based DTI for non-terminal DAI assessment in preclinical studies.
Structured Application of Genetic Testing in a Pediatric Kidney Clinic
Salcedo-Giraldo, Jordy , Wink, K , Dadzie, Nicholas , Freiman, Andrew , Pyle, Louise C. , Gordish‐Dressman, Heather , Moxey‐Mims, Marva , Dahl, Neera K. , Guay‐Woodford, Lisa M. , Gulati, Ashima , Wink, Krista R , Pyle, Louise C , Dahl, Neera K

Journal of the American Society of Nephrology | July 29, 2025 | Volume: 37 | Issue: 1 | Pages: 120-130

10.1681/asn.0000000816 | PMID 40728892 Get It

Key Points The growing knowledge of single-gene causes of pediatric-onset kidney diseases necessitates a structured application of genetic testing in practice. The clinical application of a combined nephrogenetics approach for management of kidney diseases is not well described in pediatric settings. Real-world application of a kidney genetics workflow highlights clinical value and challenges to be addressed for its successful implementation. Background The expanding knowledge of identifiable genetic contributions to pediatric inherited kidney diseases, and the increasing availability of genetic testing resources necessitates a combined nephrogenetics clinical approach. Although such models are described for adults, the effect of a structured nephrogenetics workflow on children with inherited kidney disease has not been rigorously evaluated. Methods Clinical and genetic data of patients aged younger than 1–21 years over a 10-year period between 2014 and 2024 from a single-center pediatric inherited kidney disease outpatient program were evaluated. Genetic variants were classified as pathogenic/likely pathogenic and variants of uncertain significance (VUS). Patients were grouped into “informative” or “uninformative” groups based on the effect of genetic test results on disease management and outcomes. Results Of the N =356 patients evaluated for a known or suspected inherited kidney disease, N =188 received clinical genetic testing. Of these, N =147 had an “informative” genetic test affecting at least one positive clinical outcome. Patients with an “informative” genetic test mostly harbored a pathogenic/likely pathogenic variant ( N =122). An additional N =25 had a VUS reclassified as a “VUS-of-interest” affecting a positive outcome measure. Genetic test results led to change in clinical diagnosis (reverse phenotyping, 46%), informed specific diagnosis-based treatment (46%), avoided unnecessary immunosuppression (27%) or kidney biopsy (18%), and guided extrarenal evaluation (72%) in patients with an informative test. Patients with a glomerular (odds ratio [OR]=5.23; 95% confidence interval [CI], 1.96 to 13.96) or a tubular functional disease (OR=2.17; 95% CI, 1.31 to 5.59) were more likely and those with a structural kidney disease (OR=0.39; 95% CI, 0.25 to 0.60) were less likely to receive a genetic test when compared with all other disease categories combined. Conclusions This workflow integrated multidisciplinary care for children with inherited kidney disease and describes a model for actionable clinical care plans after genetic testing. Informative genetic tests were associated with positive outcomes, and notable challenges include access to combined nephrology and genetics expertise for informed testing and an effective result return including VUS interpretation.